Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele K Fielding

Showing results (11-20 of 87) with videos related to

Pageof 9
Sort By:
Reviews in Medical Virology|November 17, 2004
Measles as a potential oncolytic virusAdele K Fielding
Hematology. American Society of Hematology. Education Program|December 7, 2019
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplantAdele K Fielding
Clinical Medicine Insights. Oncology|February 21, 2012
Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemiaLydia Lee, Adele K Fielding
Hematology. American Society of Hematology. Education Program|December 17, 2008
The treatment of adults with acute lymphoblastic leukemiaAdele K Fielding, Adele Fielding
British Journal of Haematology|November 15, 2020
Editors' Introduction to special issueAdele K Fielding, John Barrett
British Journal of Haematology|November 15, 2020
Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALLAdele K Fielding, Anthony H Goldstone
Seminars in Hematology|December 1, 2020
Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurementJack Bartram, Bela Patel, Adele K Fielding
Cancer Research|October 16, 2003
Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expressionDeanna Grote, Roberto Cattaneo, Adele K Fielding
Human Vaccines & Immunotherapeutics|November 2, 2018
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignanciesRichard Burt, Dana Warcel, Adele K Fielding
Current Hematologic Malignancy Reports|April 6, 2012
Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphomaAdele K Fielding, Lalita Banerjee, David I Marks
Pageof 9

Showing results (11-20 of 87) with videos related to

Sort By:
Pageof 9
Reviews in Medical Virology|November 17, 2004
Measles as a potential oncolytic virusAdele K Fielding
Hematology. American Society of Hematology. Education Program|December 7, 2019
Curing Ph+ ALL: assessing the relative contributions of chemotherapy, TKIs, and allogeneic stem cell transplantAdele K Fielding
Clinical Medicine Insights. Oncology|February 21, 2012
Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemiaLydia Lee, Adele K Fielding
Hematology. American Society of Hematology. Education Program|December 17, 2008
The treatment of adults with acute lymphoblastic leukemiaAdele K Fielding, Adele Fielding
British Journal of Haematology|November 15, 2020
Editors' Introduction to special issueAdele K Fielding, John Barrett
British Journal of Haematology|November 15, 2020
Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALLAdele K Fielding, Anthony H Goldstone
Seminars in Hematology|December 1, 2020
Monitoring MRD in ALL: Methodologies, technical aspects and optimal time points for measurementJack Bartram, Bela Patel, Adele K Fielding
Cancer Research|October 16, 2003
Neutrophils contribute to the measles virus-induced antitumor effect: enhancement by granulocyte macrophage colony-stimulating factor expressionDeanna Grote, Roberto Cattaneo, Adele K Fielding
Human Vaccines & Immunotherapeutics|November 2, 2018
Blinatumomab, a bispecific B-cell and T-cell engaging antibody, in the treatment of B-cell malignanciesRichard Burt, Dana Warcel, Adele K Fielding
Current Hematologic Malignancy Reports|April 6, 2012
Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphomaAdele K Fielding, Lalita Banerjee, David I Marks
Pageof 9